Feed ANRO
AN

Alto Neuroscience, Inc.

ANRO · NYSE

$26.56 -0.37% (-$0.10)
1M -24.87%
Market Cap $932.1M
P/E Ratio -
Div. Yield -
ROE 46.46%
Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Weak
2/9
Valuation
47 /100
Fair
P/B 4.25x
P/E N/A
P/FFO N/A
Growth
-
N/A
EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
37 /100
Average
ROIC 18.43%
Asset turnover 0.00x
ROE 46.46%
Debt
69 /100
Low
Debt/Equity 0.03x
Int. coverage -36.26x
Current ratio 14.85x
Stability
41 /100
Moderate
Beta 1.16x
Profitable years 0
EPS volatility 49.23%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o ANRO
Online

O podjetju

ANRO is a Czech company founded in 1993, specializing in the production and sale of a wide range of building materials, particularly insulation and waterproofing systems. ANRO focuses on innovative technologies that improve energy efficiency and extend the lifespan of buildings. The company holds a strong position in the Czech market and also operates in several other European markets, where it has built a reputation as a high-quality and reliable supplier of construction materials.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

Amit Etkin

Employees

68

Headquarters

Mountain View

Prihajajoči dogodki

11 NOV.

Earnings

Upcoming earnings report

42d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.